DALACIN

This brand name is authorized in Croatia, Ecuador, Estonia, Finland, Ireland, Israel, Japan, Malta, Mexico, Poland, South Africa, Spain, UK.

Active ingredients

The drug DALACIN contains one active pharmaceutical ingredient (API):

1	Clindamycin UNII EH6D7113I8 - CLINDAMYCIN PHOSPHATE
	Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.
	Read more about Clindamycin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DALACIN CREAM Vaginal Cream	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D10AF01	Clindamycin	D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AF Antiinfectives for treatment of acne
Discover more medicines within D10AF01
G01AA10	Clindamycin	G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AA Antibiotics
Discover more medicines within G01AA10
J01FF01	Clindamycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FF Lincosamides
Discover more medicines within J01FF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28523-07-08
EE	Ravimiamet	1011160, 1023938, 1776517
ES	Centro de información online de medicamentos de la AEMPS	49152, 58782, 58783, 60034, 62911
FI	Lääkealan turvallisuus- ja kehittämiskeskus	066707, 151852, 151860, 412064, 464891, 494542, 539973, 588574, 596031, 597401
GB	Medicines & Healthcare Products Regulatory Agency	138622, 142195, 26801
HR	Agencija za lijekove i medicinske proizvode	HR-H-363197910
IE	Health Products Regulatory Authority	19685, 30587
IL	מִשְׂרַד הַבְּרִיאוּת	2871, 4402
JP	医薬品医療機器総合機構	6112001M1031, 6112001M2038
MT	Medicines Authority	PI770/11001A, PI770/11002A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	158M92, 484M2000
PL	Rejestru Produktów Leczniczych	100075041, 100350790, 100353155, 100433948, 100451834, 100465810
ZA	Health Products Regulatory Authority	27/20.1.1/0292, 36/20.1.1/0007